Sometime in the late summer, exact date unknown, officials for the Trump Administration decline an offer from Pfizer to buy additional doses of a future COVID-19 vaccine.
Trump administration officials passed when Pfizer offered in late summer to sell the U.S. government additional doses of its Covid-19 vaccine, according to people familiar with the matter. Now Pfizer may not be able provide more of its vaccine to the United States until next June because of its commitments to other countries, they said.
The New York Times
The administration’s current purchase agreement with Pfizer only covers 50 million Americans — about 15% of the U.S. population.
The issue is not resolved by December when the vaccine is ready for approval and other countries have paid to receive their supply first.
Source
Photo: Marco Verch (License) (Cropped)
